FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2735475741> ?p ?o ?g. }

• W2735475741 abstract "Aim We propose to estimate the prevalence of Fabry disease among diagnosed hypertrophic dilated cardiomyopathy (HCM) and unexplained left ventricular hypertrophy (LVH) patients attending St. James Hospital between 2013–2015. Methods Patients invited from cardiology outpatients department (OPD) and implantable cardiac defibrillator (ICD) clinic for screening. Ongoing search for new patients diagnosed with HCM and LVH via echo report, cardiac MRI, device implantation list and from OPD list. A database created. When patients arrived, they are informed regarding Fabry disease, manifestation and implications of having this test and consented for blood testing. Fabry disease symptoms and signs survey form were also completed along family pedigree. Blood samples obtained and bar coded for traceability in the local laboratory and sent via courier to Royal Free Hospital within 72 hours. If the results were positive they were called to clinic for further discussion regarding the implications and will be referred to a metabolic consultant in Mater Misericordiae University Hospital and for nephrology consultant for renal assessment in St. James Hospital. If the blood test were negative they were informed over the phone and letter sent to patient, their general practice (GP) and a copy inserted into their chart. Results were entered into excel spreadsheet and SPSS programmer for analysis. Results 126 patients with diagnosis of HCM and LVH patients invited to have blood test for Fabry disease. Only 70 (60%) accepted the offer and had the blood test performed. Male patients (63%) had enzyme levels analysis; meanwhile female patients (37%) had enzyme level and DNA analysis specific for Fabry disease. Of the 70 patients, mean age was 52 ± 16 years old, 90% had diagnosis of HCM and 10% had unexplained LVH. Four percent (1 male and 2 female) patients of screened patient has been diagnosed Fabry disease. The prevalence of our cohort study was 4%. One of the diagnosed male patient who has renal impairment had been commenced on Fabraenzyme therapy. One female patient who has renal impairment refused the treatment and the third patient who has eGFR 67 ml/l undergoing assessment from nephrologist and a metabolic consultant specialist. Interestingly we also noted that there were five (three female and further two male) patients noted to have intronic mutations. One of the five patient who had HCM with obstructive features, had lower range of enzyme level. He had patchy late gadolinium enhancement and estimated eGFR 70 ml/min, lower than expected for his age. DNA analysis done which showed two intronic mutations noted and he was diagnosed as late onset Fabry disease and the prevalence in our population rises up to 6%. He was referred for suitability assessment for enzyme replacement therapy. Conclusion Fabry disease is still a rare genetic disorder, the prevalence in our population is about 6%. Intronic mutations are less understood. This raises question whether everyone should have full DNA analysis regardless of the gender. It is treatable disease with enzyme therapy to herald major late complications. It should be routinely used to screen patients presenting with HCM and unexplained LVH." @default.
• W2735475741 created "2017-07-21" @default.
• W2735475741 creator A5018705679 @default.
• W2735475741 creator A5044550584 @default.
• W2735475741 creator A5066405048 @default.
• W2735475741 creator A5085585725 @default.
• W2735475741 date "2016-09-28" @default.
• W2735475741 modified "2023-09-27" @default.
• W2735475741 title "66 Prevalence of fabry disease among patients diagnosed hypertrophic cardiomyopathy and unexplained left ventricular hypertrophy in ST. James Hospital (2013–2015)" @default.
• W2735475741 doi "https://doi.org/10.1136/heartjnl-2016-310523.66" @default.
• W2735475741 hasPublicationYear "2016" @default.
• W2735475741 type Work @default.
• W2735475741 sameAs 2735475741 @default.
• W2735475741 citedByCount "0" @default.
• W2735475741 crossrefType "proceedings-article" @default.
• W2735475741 hasAuthorship W2735475741A5018705679 @default.
• W2735475741 hasAuthorship W2735475741A5044550584 @default.
• W2735475741 hasAuthorship W2735475741A5066405048 @default.
• W2735475741 hasAuthorship W2735475741A5085585725 @default.
• W2735475741 hasConcept C126322002 @default.
• W2735475741 hasConcept C164705383 @default.
• W2735475741 hasConcept C187212893 @default.
• W2735475741 hasConcept C2776002628 @default.
• W2735475741 hasConcept C2777404818 @default.
• W2735475741 hasConcept C2778198053 @default.
• W2735475741 hasConcept C2778797674 @default.
• W2735475741 hasConcept C2779134260 @default.
• W2735475741 hasConcept C2779599708 @default.
• W2735475741 hasConcept C2780185194 @default.
• W2735475741 hasConcept C71924100 @default.
• W2735475741 hasConcept C84393581 @default.
• W2735475741 hasConceptScore W2735475741C126322002 @default.
• W2735475741 hasConceptScore W2735475741C164705383 @default.
• W2735475741 hasConceptScore W2735475741C187212893 @default.
• W2735475741 hasConceptScore W2735475741C2776002628 @default.
• W2735475741 hasConceptScore W2735475741C2777404818 @default.
• W2735475741 hasConceptScore W2735475741C2778198053 @default.
• W2735475741 hasConceptScore W2735475741C2778797674 @default.
• W2735475741 hasConceptScore W2735475741C2779134260 @default.
• W2735475741 hasConceptScore W2735475741C2779599708 @default.
• W2735475741 hasConceptScore W2735475741C2780185194 @default.
• W2735475741 hasConceptScore W2735475741C71924100 @default.
• W2735475741 hasConceptScore W2735475741C84393581 @default.
• W2735475741 hasLocation W27354757411 @default.
• W2735475741 hasOpenAccess W2735475741 @default.
• W2735475741 hasPrimaryLocation W27354757411 @default.
• W2735475741 hasRelatedWork W1988198018 @default.
• W2735475741 hasRelatedWork W1996297576 @default.
• W2735475741 hasRelatedWork W2345763234 @default.
• W2735475741 hasRelatedWork W2373549793 @default.
• W2735475741 hasRelatedWork W2375377575 @default.
• W2735475741 hasRelatedWork W2395606794 @default.
• W2735475741 hasRelatedWork W2417010340 @default.
• W2735475741 hasRelatedWork W2473616306 @default.
• W2735475741 hasRelatedWork W2550909419 @default.
• W2735475741 hasRelatedWork W2621817236 @default.
• W2735475741 hasRelatedWork W2773722208 @default.
• W2735475741 hasRelatedWork W2776829622 @default.
• W2735475741 hasRelatedWork W2808797739 @default.
• W2735475741 hasRelatedWork W2909413552 @default.
• W2735475741 hasRelatedWork W3019613353 @default.
• W2735475741 hasRelatedWork W3035350472 @default.
• W2735475741 hasRelatedWork W3092585138 @default.
• W2735475741 hasRelatedWork W3112436270 @default.
• W2735475741 hasRelatedWork W3116247369 @default.
• W2735475741 hasRelatedWork W3164742621 @default.
• W2735475741 isParatext "false" @default.
• W2735475741 isRetracted "false" @default.
• W2735475741 magId "2735475741" @default.
• W2735475741 workType "article" @default.